When it comes to delivering prescription drugs to Americans, the U.S. Postal Service may as well be the Pony Express, at least judging by the delays that mail-order pharmacies reported to two lawmakers.

So far this year, the average delivery time in which the postal service delivered prescriptions increased by 18% to 32%, which means deliveries that would typically take two to three days instead took three to four days, according to a new report issued by Sen. Elizabeth Warren (D-Mass.) and Sen. Bob Casey (D-Pa.).

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • I wonder how many of these drugs are temperature sensitive ? One would think that these drugs would lose their effectiveness traveling thru these mail facilities for who knows how many days and who knows at what temperature. You gotta hand it to those PBM’s insisting
    on mandatory 90 day mail order.They obviously only are concerned about their profits !!!

Comments are closed.

Sign up to receive a free weekly opinions recap from our community of experts.
Privacy Policy